Muldashev claims to have invented Allplant after an expedition in Tibet gave him innate and unprecedented understanding of certain worldly ideas and concepts beyond peer-reviewed medicine.
[1] Muldashev has claimed variously that Alloplant works by regenerating dead tissue it's in contact with, or by attracting stem cells that proceed to differentiate to rebuild damaged structures in the eye, or prevent further spread of the condition.
[1] He claims this material, surgically implanted in the eye, will help cure or stop the progression of a vast array of diseases and conditions, such as retinitis pigmentosa, diabetic retinopathy, age-related macular degeneration, optic nerve atrophy, glaucoma, progressive myopia and retinopathy of prematurity.
[3][1][2] Expert ophthalmologists contacted by the media say scientific literature include no studies validating Muldashev's claims about Alloplant.
[2] Two ophthalmologists from Nevada had published a paper in 2008 concluding that the alloplant method reduced intraocular pressure, one of the main ways of treating glaucoma, and assisted tissue regeneration.